Throughout the last three months, 8 analysts have evaluated Welltower WELL, offering a diverse set of opinions from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 3 | 3 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 0 | 1 | 0 | 0 | 0 |
2M Ago | 1 | 1 | 2 | 0 | 0 |
3M Ago | 0 | 1 | 1 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $94.88, a high estimate of $101.00, and a low estimate of $89.00. This upward trend is evident, with the current average reflecting a 5.76% increase from the previous average price target of $89.71.
Understanding Analyst Ratings: A Comprehensive Breakdown
The analysis of recent analyst actions sheds light on the perception of Welltower by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Omotayo Okusanya | Mizuho | Raises | Buy | $98.00 | $90.00 |
Michael Mueller | JP Morgan | Raises | Overweight | $99.00 | $92.00 |
Michael Carroll | RBC Capital | Raises | Sector Perform | $97.00 | $92.00 |
Steve Sakwa | Evercore ISI Group | Raises | In-Line | $89.00 | $86.00 |
Todd Stender | Wells Fargo | Raises | Overweight | $95.00 | $93.00 |
Jonathan Hughes | Raymond James | Raises | Strong Buy | $101.00 | $95.00 |
Todd Thomas | Keybanc | Raises | Overweight | $90.00 | $80.00 |
Michael Mueller | JP Morgan | Announces | Neutral | $90.00 | - |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Welltower. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Welltower compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Welltower's stock. This comparison reveals trends in analysts' expectations over time.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Welltower's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Welltower analyst ratings.
Discovering Welltower: A Closer Look
Welltower owns a diversified healthcare portfolio of over 2,000 in-place properties spread across the senior housing, medical office, and skilled nursing/post-acute care sectors. The portfolio includes over 100 properties in both Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.
Financial Insights: Welltower
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Welltower displayed positive results in 3 months. As of 30 September, 2023, the company achieved a solid revenue growth rate of approximately 12.77%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: Welltower's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 7.67%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Welltower's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 0.58%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Welltower's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.31% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.71.
The Significance of Analyst Ratings Explained
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.